
Elizabeth McKenna/X
Mar 24, 2025, 13:36
Elizabeth McKenna: PGV001 in Patients with Solid and Hematological Malignancies
Elizabeth McKenna, Executive Director of Cancer Discovery at the American Association for Cancer Research, shared an article by Mansi Saxena, et al. on X:
“Now in Cancer Discovery:
PGV001, a Multi-Peptide Personalized Neoantigen Vaccine Platform:
Phase I Study in Patients with Solid & Hematological Malignancies in the Adjuvant Setting – by Mansi Saxena, Tom Marron, Philip Friedlander, Alex rubinsteyn, Bhardwaj Lab, et al.”
PGV001, a multi-peptide personalized neoantigen vaccine platform: Phase I study in patients with solid and hematological malignancies in the adjuvant setting.
Authors: Mansi Saxena, et al.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Mar 26, 2025, 19:51
Mar 26, 2025, 18:12
Mar 26, 2025, 18:03